Stock Information
Olema Pharmaceuticals Inc (OLMA)
Ticker Symbol: OLMA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,020.29 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.8643
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -42.9%
Latest News
-
Olema Pharma Announces Clinical Trial Collaboration And Supply Agreement With Bayer To Evaluate OP-3136 In Combination With NUBEQA In Patients With mCRPC
Tue, May 26, 2026 7:04 AM
-
Olema Pharmaceuticals Reports Initial Clinical Data From The Phase 1 Study of OP-3136, A KAT6 Inhibitor, At 2026 ASCO Annual Meeting; OP-3136 Monotherapy Was Well-tolerated With No Dose-limiting Toxicities Observed And No Discontinuations Due To Treatment-related Adverse Events; OP-3136 Shows Evidence Of Anti-tumor Activity Across Multiple Solid Tumor Types
Thu, May 21, 2026 5:08 PM
Key Financials
Financial data not available
